GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7KS9 | P0DTC2 | Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab | |
7KSG | P0DTC2 | SARS-CoV-2 spike in complex with nanobodies E | SARS-CoV-2 spike glycoprotein, Nanobody against SARS-CoV-2 glycoprotein |
7KXJ | P0DTC2 | SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric | |
7KXK | P0DTC2 | SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation | |
7KZB | P0DTC2 | Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies | |
7L02 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 | 2G12 heavy chain, 2G12 light chain, Spike glycoprotein |
7L0N | P0DTC2 | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
7L2C | P0DTC2 | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
7L57 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | Spike glycoprotein, Fab 2-15 variable domain heavy chain, Fab 2-15 variable domain light chain |
7LAB | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
7LWM | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | |
7LWO | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | |
7LWT | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
7LWU | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
7LXX | P0DTC2 | SARS-CoV-2 S/S2M11/S2L28 Local Refinement | S2L28 Fab Heavy Chain variable region, S2L28 Fab Light Chain variable region, Spike glycoprotein |
7LY3 | P0DTC2 | Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab | |
7LYK | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformation | |
7LYQ | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
7M3I | P0DTC2 | Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibody, CV2-75 Fab | |
7M6E | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG10-19 | Spike glycoprotein, BG10-19 Fab Heavy Chain, BG10-19 Fab Light Chain |
7M6H | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20 | Spike glycoprotein, BG7-20 Fab Heavy Chain, BG7-20 Fab Light Chain |
7MDW | P0DTC2 | CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 | |
7MJM | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain | Spike glycoprotein, Processed angiotensin-converting enzyme 2 |
7MKL | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation) | |
7MTE | P0DTC2 | Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment | |
6XKQ | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 | |
6ZP1 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Closed State | Matrix protein 1 |
6ZP2 | P0DTC2 | Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Locked State | |
6ZP5 | P0DTC2 | SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation) | |
7A5S | P0DTC2 | Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement) | CR3022 Fab Heavy Chain, CR3022 Fab Light Chain, Spike glycoprotein,Surface glycoprotein |
7A94 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound | Spike glycoprotein |
7B62 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin | |
7BEO | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253H55L and COVOX-75 Fabs | |
7CHO | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD | |
7CT5 | P0DTC2 | S protein of SARS-CoV-2 in complex bound with T-ACE2 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7DWZ | P0DTC2 | S protein of SARS-CoV-2 in the active conformation | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7DX8 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7E3J | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
7E7B | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
7E8M | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
7EJ4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 | Spike glycoprotein, RBD-chAb-25, Heavy chain, RBD-chAb-25, Light chain |
7KL9 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) | Spike glycoprotein, CTC-445.2 inhibitor |
7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LWK | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
7LWQ | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer | |
7LWW | P0DTC2 | Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y) | |
7LY2 | P0DTC2 | SARS-CoV-2 S/S2M11/S2M28 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2M28 Fab Heavy Chain variable region, S2M28 Fab Light Chain variable region |
7MM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MTD | P0DTC2 | Structure of aged SARS-CoV-2 S2P spike at pH 7.4 | |
7MY3 | P0DTC2 | CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024